Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

Therapeutic Support

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 12, 2026 · PHASE 2 TRIAL

Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality

ClinicalTrials.gov

This is an active Phase 2 feasibility and safety study with no results posted; it measures acceptability and tolerability in a small planned cohort (n=10) with suicidality as a secondary focus, not a completed trial with efficacy data.

PreliminaryThe University of Texas Health Science Center, Houston Therapeutic Support Suicidality

Reported

Planned sample size10

Psilocybin dose25 mg

PhasePhase 2

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support